CHEBI:18259 - N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
ChEBI ID CHEBI:18259
ChEBI ASCII Name N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Definition A glycotetraosylceramide having N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucose as the tetrasaccharide component.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:36509, CHEBI:21508, CHEBI:21513, CHEBI:12452, CHEBI:5388, CHEBI:12557, CHEBI:24252
Download Molfile XML SDF
Formula C45H79N2O23R
Net Charge 0
Average Mass (excl. R groups) 1016.10840
Monoisotopic Mass (excl. R groups) 1015.50736
SMILES CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC([*])=O
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Homo sapiens (NCBI:txid9606) See: DOI
Roles Classification
Biological Role(s): human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
(via N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) has part →4)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-yl group (CHEBI:142533)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) has part α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-yl group (CHEBI:142567)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) has role antigen (CHEBI:59132)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) has role human metabolite (CHEBI:77746)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) has role mouse metabolite (CHEBI:75771)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) is a N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:88167)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) is a globoside (CHEBI:61360)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259) is a glycotetraosylceramide (CHEBI:23075)
Incoming β-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-N-acylsphingosine (CHEBI:140784) has functional parent N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259)
SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-ceramide(d18:1 (4E)) (CHEBI:141158) has functional parent N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259)
N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (d18:1/16:0) (CHEBI:132968) is a N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259)
N-acetyl-D-galactosaminyl-(1→3)-D-galactosyl-(1→4)-D-galactosyl-(1→4)-D-glucosyl-N-stearoylceramide (CHEBI:52988) is a N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259)
globoside Gb4 (CHEBI:84125) is a N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18259)
IUPAC Name
N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→3)-α-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
Synonyms Sources
(Gal)2 (GalNAc)1 (Glc)1 (Cer)1 KEGG GLYCAN
β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer JCBN
β-D-GalpNAc-(1→3)-α-D-Galp-(1→4)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer JCBN
CTH/Gb4 ChEBI
GalNAc-1→3-Gal-1→4-Gal-1→4-Glc-Cer ChemIDplus
GalNAcβ1-3-Galα1-4Galβ1-4Glcβ1-1Cer ChEBI
Gb4 Globoside ChemIDplus
Gb4 Globotetraosyl ceramide ChemIDplus
Gb4Cer ChemIDplus
Gb4Cer KEGG GLYCAN
Gbose4Cer ChemIDplus
GbOse4Cer ChEBI
globoside Gb4Cer (d18:1(4E)) UniProt
Globoside GL-4 ChemIDplus
Globoside I KEGG COMPOUND
Globotetraosyl ceramide ChemIDplus
N-acetyl-D-galactosaminyl-(1→3)-D-galactosyl-(1→4)-D-galactosyl-(1→4)-D-glucosylceramides ChEBI
N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide KEGG COMPOUND
N-Acetyl-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide KEGG COMPOUND
Slt-iiv receptor ChemIDplus
VT2vp1 Receptor ChemIDplus
Manual Xrefs Databases
C03272 KEGG COMPOUND
G00094 KEGG GLYCAN
View more database links
Registry Numbers Types Sources
11034-93-8 CAS Registry Number KEGG COMPOUND
11034-93-8 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
1528196 PubMed citation Europe PMC
15495792 PubMed citation Europe PMC
15661151 PubMed citation Europe PMC
1601891 PubMed citation Europe PMC
1724444 PubMed citation Europe PMC
21252262 PubMed citation Europe PMC
21376640 PubMed citation Europe PMC
2448252 PubMed citation Europe PMC
2456994 PubMed citation Europe PMC
3220436 PubMed citation Europe PMC
4026313 PubMed citation Europe PMC
7287743 PubMed citation Europe PMC
7690848 PubMed citation Europe PMC
7691279 PubMed citation Europe PMC
8161226 PubMed citation Europe PMC
Last Modified
13 November 2018